483
Aucta Pharmaceuticals, Inc.FDA 483 - Aucta Pharmaceuticals, Inc. - October 03, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Aucta Pharmaceuticals, Inc. in Piscataway, NJ, revealed a significant deviation from written production and process control procedures. The firm failed to conduct a required performance qualification study for a mixer used in the manufacturing of a drug product, (b) (4) Oral Suspension. This indicates a lapse in equipment validation and adherence to internal quality management plans.
Open in Dashboard
ID · 04b2586e-46db-4320-ad8e-9157e80e719a